{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:06:25Z","timestamp":1762272385666,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.eimc.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T17:12:08Z","timestamp":1557249128000},"page":"25-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Actividad in vitro de la combinaci\u00f3n de ceftarolina con otros antimicrobianos activos frente a Staphylococcus spp"],"prefix":"10.1016","volume":"38","author":[{"given":"Yolanda","family":"Gil Romero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Luis","family":"G\u00f3mez-Garc\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Supl 2","key":"10.1016\/j.eimc.2019.03.007_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0213-005X(14)70151-X","article-title":"Ceftarolina, un nuevo antimicrobiano de amplio espectro en la era de las multirresistencias","volume":"32","author":"Horcajada","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2019.03.007_bib0040","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.clinthera.2014.09.005","article-title":"Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus","volume":"36","author":"Dhand","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/j.eimc.2019.03.007_bib0045","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.diagmicrobio.2013.07.006","article-title":"Compararison of 3 E-test methods and time-kill assay for determination of antimicrobial synergy carbapenemase-producing Klebsiella species","volume":"77","author":"Pankey","year":"2013","journal-title":"Diagnostic Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2019.03.007_bib0050","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00502-12","article-title":"Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combination with other antibiotics","volume":"56","author":"Berti","year":"2012","journal-title":"Antimicrob Agents Chemother."},{"key":"10.1016\/j.eimc.2019.03.007_bib0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40121-014-0023-0","article-title":"Observation of \u201cseesaw effect\u201d with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA Strains","volume":"3","author":"Barber","year":"2014","journal-title":"Infect Dis Ther."},{"key":"10.1016\/j.eimc.2019.03.007_bib0060","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1099\/jmm.0.000341","article-title":"In vitro ceftaroline combinations against meticillin-resistant Staphylococcus aureus","volume":"65","author":"Garcia","year":"2016","journal-title":"J Med Microbiol"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X19301557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X19301557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:06:00Z","timestamp":1759323960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X19301557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0213005X19301557"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2019.03.007","relation":{},"ISSN":["0213-005X"],"issn-type":[{"type":"print","value":"0213-005X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actividad in vitro de la combinaci\u00f3n de ceftarolina con otros antimicrobianos activos frente a Staphylococcus spp","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}